普健生物(武汉)科技有限公司(AtaGenix)

Recombinant Human IL3RA protein ,C- His Tag

  • 1
ATMP00317HU
-
+
现货
加入购物车
收藏
  • 产品信息(Product Details)
  • 前沿进展(Frontier progress)
  • 如何订购
  • 说明书
概述(Summary)icon
英文全称
Recombinant Human IL3RA protein ,C- His Tag
纯度(Purity)
>90% as determined by SDS-PAGE
内毒素(Endotoxin level)
Please contact with the lab for this information.
蛋白构建(Construction)
A DNA sequence encoding the human IL3RA(Met1-Arg305) was fused with the C-terminal His Tag
Accession #
P26951
表达宿主(Host)
Mammalian cells
种属(Species)
Homo sapiens (Human)
预测分子量(Predicted Molecular Mass)
33.55kDa
制剂(Formulation)
Supplied as solution form in PBS or lyophilized from PBS .
运输方式(Shipping)
In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.
稳定性&储存(Stability &Storage)
Use a manual defrost freezer and avoid repeated freeze thaw cycles.
Store at 2 to 8 °C for one week .
Store at -20 to -80 °C for twelve months from the date of receipt.
复溶(Reconstitution)
Reconstitute in sterile water for a stock solution.A copy of datasheet will be provided with the products, please refer to it for details.
电泳图(SDS-PAGE image)icon
    背景(Background)icon
    背景介绍
    Interleukin 3 receptor alpha (low affinity) (IL3RA), also known as CD123 (Cluster of Differentiation 123) is a 70-kD glycoprotein member of the hematopoietin receptor superfamily. This protein associates with a beta subunit common to the receptors for IL-5 and granulocyte-macrophage colony-stimulating factor (GM-CSF) to form a high-affinity receptor for IL-3. The interleukin-3 receptor α chain (CD123) has been identified as a potential immunotherapeutic target because it is overexpressed in AML compared with normal hematopoietic stem cells.
    分子别名(Alternative Names)
    IL3R,IL3RA,IL-3Ra,IL-3R-alpha,IL3RAY,IL3RX,IL3RY,CD123 antigen,CD123,hIL3Ra,hIL-3Ra,MGC34174,IL-3 R alpha
    参考文献(References)
    Rascu, Otelea, Mambet, Handra, Neagu, Rascu, Giurcaneanu, Diaconu (2020) Modified plasma cytokine profile in occupational dermatitis Endocrine, metabolic & immune disorders drug targets ()
    Noteicon
    For research use only .
    Despite significant progress in the diagnosis of contact dermatitis, the identification of specific tests or biomarkers remains an unsolved issue, particularly when needed for the confirmation of the occupational origin of the disease. To characterize the plasma proteome profile in occupational dermatitis in workers from paint industry. The study has a case-control design, comparing exposed workers with and without occupational contact dermatitis, matched for age, gender, occupational history and comorbidities. An immunological assay (Human XL Cytokine Array Kit - ARY022B, R&D Systems) was used to measure the plasma levels of 105 cytokines and chemokines in a pooled sample of the cases and a pooled sample of the controls. A 1.5-fold increase was noticed for interleukin 3, interleukin 10 and leptin in cases, as compared to controls. Fibroblast growth factor-7 and growth/differentiation factor-15 showed a 1.4- fold increase, while interleukin 19, interleukin 31 and macrophage inflammatory protein 3 α had only a 1.3-fold increase. Leukemia inhibitory factor was the only plasma cytokine that showed a 1.3-fold decrease. All other cytokines had a variation of less than 1.2-fold between cases and controls. The recognition of the molecular signatures is very important for an accurate and indisputable diagnosis of occupational contact dermatitis. In workers from paint industry, plasma levels of interleukins 3, 10, 13 and 19, fibroblast growth factor-7, and growth/differentiation factor-15 together with leukemia inducible factor may differentiate subjects with contact dermatitis from those without skin lesions.

    1搜索商品:关键字搜索;分类导航搜索;产品联系:手机/微信同号:15972188750,座机:027-65279366(推荐 !

    2产品选购:确定好产品信息与规格,向产品客服询问底价

    3提交订单:向客服提交收货人信息,选择送货方式,支付方式,发票信息

    4产品发货:发票随产品一起发送,耐心等待收货即可


    质量保证:

    所售产品均经过严格的质量检验,确保所供产品的技术指标与生产厂家的目录、说明书、质检报告上的描述一致,请放心选购。


    质量与免责说明:

    买方验收产品时,如发现产品短缺、不匹配、包装破损等情况,请保持产品原包装状态,并在收货七个工作日内,以书面方式向我司提出异议。逾期未提出异议视为合格。

    买方保管产品时,应按照产品标签、说明书所示保管条件保存,如系保管不当导致产品质量问题,恕不受理。

    买方使用产品时。如发现产品质量问题,应在使用初期提出,而非在使用完或快使用完时提出,以备我司回收产品,确认产品质量。如确属质量问题,我司负责调换或退货。发生索赔事宜,我司将在产品价格额度范围内酌情赔偿,恕不受理超出产品本身价值之部分。自收货之日起,超过三个月未反映产品问题,恕不退换。

    我司所提供的产品仅限于专业人士的科学研究使用,不得用于临床诊断或者治疗,若有单位或者个人擅自改变我司产品用途,我司不承担任何责任。